HEATHER GREEN: Open Payments
NPI 1427355940 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 32 payments from 14 companies in 2025. Trend: 2023 $842 · 2024 $718 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 9 | $219 |
| Otsuka America Pharmaceutical, Inc. | 5 | $133 |
| Amgen Inc. | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Fresenius USA Marketing, Inc. | 3 | $51 |
| Travere Therapeutics, Inc. | 2 | $49 |
| Recor Medical Inc | 1 | $31 |
| Ardelyx, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $25 |
| Veloxis Pharmaceuticals, Inc. | 1 | $25 |
Products named: TARPEYO, JYNARQUE, TAVNEOS, TERLIVAZ, VELPHORO, Paradise Ultrasound Renal Denervation System, IBSRELA, Ozempic.
Industry payments across SC — which companies pay providers there.
